Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study

Clinical and Translational Radiation Oncology - Tập 4 - Trang 51-56 - 2017
Theodora A. Koulis1,2, Elizabeth N. Kornaga3, Robyn Banerjee1,2, Tien Phan1,2, Prafull Ghatage1,4, Anthony M. Magliocco3, Susan P. Lees-Miller5, Corinne M. Doll1,2
1Department of Oncology, University of Calgary, Cumming School of Medicine, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada
2Division of Radiation Oncology, Tom Baker Cancer Centre, 1331 29 St NW, Calgary, AB T2N 4N2, Canada
3Translational Laboratories, Tom Baker Cancer Centre, Alberta Health Services, 1331 29 St NW, Calgary, AB T2N 4N2, Canada
4Division of Gynecologic Oncology, Tom Baker Cancer Centre, 1331 29 St NW, Calgary, AB T2N 4N2, Canada
5Department of Biochemistry and Molecular Biology and Oncology, University of Calgary, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada

Tài liệu tham khảo

Girinski, 1989, Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients, Int J Radiat Oncol Biol Phys, 16, 37, 10.1016/0360-3016(89)90007-2 Winter, 2004, Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study, Gynecol Oncol, 94, 495, 10.1016/j.ygyno.2004.04.008 Grogan, 1999, The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix, Cancer, 86, 1528, 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E Thomas, 2001, The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience, Semin Oncol, 28, 60, 10.1016/S0093-7754(01)90215-5 Doll, 2013, The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis, Int J Radiat Oncol Biol Phys, 85, 721, 10.1016/j.ijrobp.2012.06.021 Barkati, 2013, Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype, Int J Gynecol Cancer, 23, 724, 10.1097/IGC.0b013e31828a0623 Fyles, 2000, Anemia, hypoxia and transfusion in patients with cervix cancer: a review, Radiother Oncol, 57, 13, 10.1016/S0167-8140(00)00245-0 Bishop, 2015, Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated?, Int J Radiat Oncol Biol Phys, 91, 196, 10.1016/j.ijrobp.2014.09.023 Banerjee, 2013, The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy, Dis Colon Rectum, 56, 1036, 10.1097/DCR.0b013e31829ab0d4 Tavares-Murta, 2010, Systemic leukocyte alterations are associated with invasive uterine cervical cancer, Int J Gynecol Cancer, 20, 1154, 10.1111/IGC.0b013e3181ef8deb Garcia-Arias, 2007, The prognostic significance of leukocytosis in cervical cancer, Int J Gynecol Cancer, 17, 465, 10.1111/j.1525-1438.2007.00816.x Mabuchi, 2011, Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer, Gynecol Oncol, 122, 25, 10.1016/j.ygyno.2011.03.037 Qiu, 2010, Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China, Tumour Biol, 31, 633, 10.1007/s13277-010-0079-8 Cho, 2016, Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients, Ann Oncol, 27, 2067, 10.1093/annonc/mdw308 Escande, 2016, Neutrophilia in locally advanced cervical cancer: a novel biomarker for image-guided adaptive brachytherapy?, Oncotarget, 7, 74886, 10.18632/oncotarget.12440 Chassagne D, Dutreix A, Almond P, Burgers J, Busch M, Joslin C. ICRU Report No. 38, Dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda: International commissioning on radiation units and measurements; 1985. Demirci, 2012, Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy, Eur J Gynaecol Oncol, 33, 62 Seo, 2011, Nomogram prediction of overall survival after curative irradiation for uterine cervical cancer, Int J Radiat Oncol Biol Phys, 79, 782, 10.1016/j.ijrobp.2009.11.054 Thomas, 2008, Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer, Gynecol Oncol, 108, 317, 10.1016/j.ygyno.2007.10.011 Lee, 2012, Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma, Anticancer Res, 32, 1555 Mizunuma, 2015, The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer, Int J Clin Oncol, 20, 989, 10.1007/s10147-015-0807-6 Dirican, 2015, Association of intratumoral tumor infiltrating lymphocytes and neutrophil-to- lymphocyte ratio are an independent prognostic factor in non-small cell lung cancer, Clin Respir J